Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor α antagonist etanercept
- 1 January 2002
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 46 (1) , 113-115
- https://doi.org/10.1067/mjd.2001.119100
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cicatricial pemphigoidJournal of the American Academy of Dermatology, 2000
- An open clinical trial of sulphamethoxypyridazine in the treatment of mucous membrane pemphigoidBritish Journal of Dermatology, 2000
- A case of antiepiligrin cicatricial pemphigoid successfully treated by plasmapheresis.Dermatology, 2000
- A retrospective study of the management of oral mucous membrane pemphigoid with dapsoneOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 1999
- Recent advances in the treatment of rheumatoid arthritisClinical Cornerstone, 1999
- Increased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activityJournal of the European Academy of Dermatology and Venereology, 1999
- Epidermal adhesion molecules and basement membrane components as target structures of autoimmunityVirchows Archiv, 1998
- Cytokine pattern in blister fluid and serum of patients with bullous pemphigoid: relationships with disease intensityBritish Journal of Dermatology, 1998
- Cicatricial Pemphigoid Successfully Treated With Pulse Intravenous CyclophosphamideArchives of Dermatology, 1997
- Das vernarbende Pemphigoid ? ein therapeutisches ProblemDie Dermatologie, 1995